SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. sold 14.1% of their position (10.89K shares) of NATURES SUNSHINE PRODUCTS INC on the open market
Open‑market sale worth $145.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+2.97K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−1.40K
Price / share
$13.54
Trade value
$18.94K
% of position
Common Stock
Shares
−1.80K
Price / share
$13.13
Trade value
$23.63K
% of position
Common Stock
Shares
−1.82K
Price / share
$13.36
Trade value
$24.26K
% of position
Common Stock
Shares
−3K
Price / share
$13.39
Trade value
$40.17K
% of position
Common Stock
Shares
−1.58K
Price / share
$13.37
Trade value
$21.12K
% of position
Common Stock
Shares
−1.30K
Price / share
$13.12
Trade value
$17.06K
% of position
Net shares
−7.93K
Net value
-$145.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/6/2024 | J · J | +2.97K | — | — | 4.0% | 74.39K | 77.36K |
| Common Stock Indirect | 10/1/2024 | S · Sale | −1.40K | $13.54 | $18.94K | 1.8% | 77.36K | 75.96K |
| Common Stock Indirect | 10/8/2024 | S · Sale | −1.80K | $13.13 | $23.63K | 2.4% | 75.96K | 74.16K |
| Common Stock Indirect | 10/9/2024 | S · Sale | −1.82K | $13.36 | $24.26K | 2.4% | 74.16K | 72.35K |
| Common Stock Indirect | 10/10/2024 | S · Sale | −3K | $13.39 | $40.17K | 4.1% | 72.35K | 69.35K |
| Common Stock Indirect | 10/11/2024 | S · Sale | −1.58K | $13.37 | $21.12K | 2.3% | 69.35K | 67.77K |
| Common Stock Indirect | 10/14/2024 | S · Sale | −1.30K | $13.12 | $17.06K | 1.9% | 67.77K | 66.47K |
| Total | −7.93K | -$145.19K | ||||||
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.85M | Direct |
| Total | 2.85M | 2.85M direct |